D2 dopamine receptors and modulation of spontaneous acetylcholine (ACh) release from rat striatal synaptosomes

British Journal of Pharmacology

Volumn 122, Issue 2, 1997, Pages 286-290

  Clos, M V ^a   Garcia Sanz A ^a   Vivas, N M ^a   Badia, A ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

7 OH DPAT; D2 dopamine receptors; D3 dopamine receptors; Haloperidol; Presynaptic dopamine receptors; Quinpirole; Spontaneous ACh release; Synaptosomes

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; ACETYLCHOLINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; EMONAPRIDE; HALOPERIDOL; QUINPIROLE; 7 HYDROXY 2 N,N DIPROPYLAMINOTETRALIN; 7-HYDROXY-2-N,N-DIPROPYLAMINOTETRALIN; BENZAMIDE DERIVATIVE; DOPAMINE RECEPTOR STIMULATING AGENT; PRESYNAPTIC RECEPTOR; TETRALIN DERIVATIVE;

ACETYLCHOLINE RELEASE; ANIMAL TISSUE; ARTICLE; BRAIN SYNAPTOSOME; CORPUS STRIATUM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; CHO CELL; COMPARATIVE STUDY; DRUG EFFECT; HAMSTER; HUMAN; METABOLISM; NEOSTRIATUM; PHYSIOLOGY; SPRAGUE DAWLEY RAT; SYNAPTOSOME;

ACETYLCHOLINE; ANIMALS; BENZAMIDES; CHO CELLS; CRICETINAE; DOPAMINE AGONISTS; HUMANS; MALE; NEOSTRIATUM; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; RECEPTORS, PRESYNAPTIC; SYNAPTOSOMES; TETRAHYDRONAPHTHALENES;

EID: 0030610506     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701327     Document Type: Article

References (28)

1. 2+ -independent release of neurotransmitters. J. Neurochem., 58, 395-405.
2. AHLENIUS, S. & SALMI, P. (1994). Behavioral and biochemical effects of the dopamine D3 receptor-selective ligand, 7-OH-DPAT, in the normal and the reserpine-treated rat. Eur. J. Pharmacol., 260, 177-181.
3. 3H)YM-09151-2 binding in the rat brain by thioridazine, risperidone and clozapine, but not by other antipsichotics. Eur. J. Pharmacol., 237, 183-189.
4. BRADFORD, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
5. 3 dopamine receptors. Science, 260, 1814-1816.
6. CLOS, M.V., GARCIA SANZ, A., SABRIA, J., PASTOR, C. & BADIA, A. (1994). Differential contribution of L- and N-type calcium channels on rat hippocampal acetylcholine release. Neurosci. Lett., 182, 125-128.
7. DOLEZAL, V. & WECKER, L. (1990). Muscarinic receptor blockade increases basal acetylcholine release from striatal slices. J. Pharmacol. Exp. Ther., 252, 739-743.
8. 2 receptor-mediated inhibition of acetylcholine release in rabbit striatum. Naunyn-Schmiedeberg's Arch. Pharmacol., 345, 16-20.
9. 2 dopamine receptor mediated inhibition of acetylcholine release in rat striatum: indications for a common signal transduction pathway. Neuroscience, 37, 1-9.
10. 3H]-hydroxy-N,N-di-n-propyl-2-aminotetralin. Proc. Natl. Acad. Sci. U.S.A., 89, 8156-8159.
11. 1 DA receptor-mediated control of striatal acetylcholine release in vitro. Brain Res., 681, 209-212.
12. 3 receptors. Mol. Pharmacol., 43, 749-754.
13. MARCHI, M., PAUDICE, P. & RAITERI, M. (1981). Autoregulation of ACh release in isolated hippocampal nerve endings. Eur. J. Pharmacol., 73, 75-79.
14. 3 receptors, blocks 7-OH-DPAT-induced hypothermia in rats. Eur. J. Pharmacol., 260, R3-R5.
15. 3H-acetylcholine from rat cerebral cortex slices in vitro. Br. J. Pharmacol., 47, 97-108.
16. MUNSON, P.J. & RODBARD, D. (1980). LIGAND: A versatile computerized approach for the characterization of ligand binding systems. Anal. Biochem., 107, 220-239.
17. NORDSTROM, O. & BARTFAI, T. (1980). Muscarinic autoreceptor regulates acetylcholine release in rat hippocampus: in vitro evidence. Acta Physiol. Scand., 108, 347-353.
18. 1-adrenoceptors: regional differences in cortical and hippocampal nerve terminals. Satellite Symposium, Annual meeting of the Society for Neuroscience. San Diego, U.S.A. Neuropharmacology, III, 14.
19. RAITERI, M., ANGELINI, F. & LEVI, G. (1974). A simple apparatus for studying the release of neurotransmitters from synaptosomes. Eur. J. Pharmacol., 25, 411-414.
20. ROBERTSON, G.S., THAM, C.S., WILSON, C., JAKUBOVIC, A. & FIBIGER, H.C. (1993). In vivo comparisons of the effects of quinpirole and the putative presynaptic dopaminergic agonists B-HT 920 and SND 919 on striatal dopamine and acetylcholine release. J. Pharmacol. Exp. Ther., 264, 1344-1351.
21. 3 agonist, on acetylcholine release during striatal microdialysis in conscious rats. Brain Res., 655, 233-236.
22. SIBLEY, D.R. & MONSMA JR., F.L. (1992). Molecular biology of dopamine receptors. Trends Pharmacol. Sci., 13, 61-69.
23. 3) as a target for neuroleptics. Nature, 347, 146-151.
24. 3 dopamine receptor. Arzneim-Forsch/Drug Res., 42, 224-230.
25. + stimulated release of acetylcholine from rat neostriatum. Brain Res., 250, 263-268.
26. STOOF, J.C., DRUKARCH, B., DEBOER, P., WESTERINK, B.H.C. & GROENEWEGEN, H.J. (1992). Regulation of the activity of striatal cholinergic neurons by dopamine. Neuroscience, 47, 755-759.
27. 1 muscarinic receptor modulates spontaneous release of acetylcholine from rat basal forebrain slices. Neurosci. Lett., 84, 209-212.
28. UEDA, H., SATO, K., OKUMURA, F. & MISU, Y. (1995). L-DOPA inhibits spontaneous acetylcholine release from the striatum of experimental Parkinson's model rats. Brain Res., 698, 213-216.